Suppr超能文献

相似文献

1
Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7962-7. doi: 10.1073/pnas.1105243108. Epub 2011 Apr 25.
2
Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.
Hum Mol Genet. 2008 Jan 1;17(1):98-110. doi: 10.1093/hmg/ddm287. Epub 2007 Sep 29.
3
Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3395-404. doi: 10.1073/pnas.1217982109. Epub 2012 Nov 26.
5
FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
Mol Cell Biol. 2010 Mar;30(5):1243-53. doi: 10.1128/MCB.01891-08. Epub 2010 Jan 4.
6
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Endocr Relat Cancer. 2005 Mar;12(1):119-34. doi: 10.1677/erc.1.00835.
8
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.
Cancer Res. 2013 Sep 15;73(18):5633-46. doi: 10.1158/0008-5472.CAN-12-3228. Epub 2013 Jul 22.
9
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Cancer Res. 2009 Oct 15;69(20):8102-10. doi: 10.1158/0008-5472.CAN-09-0941. Epub 2009 Sep 29.
10
Androgen receptor and invasion in prostate cancer.
Cancer Res. 2008 Feb 15;68(4):1128-35. doi: 10.1158/0008-5472.CAN-07-1929.

引用本文的文献

1
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer.
Endocr Oncol. 2022 Sep 8;2(1):R112-R131. doi: 10.1530/EO-22-0065. eCollection 2022 Jan.
2
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance.
Cancers (Basel). 2021 Nov 18;13(22):5796. doi: 10.3390/cancers13225796.
3
Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.
Cell Mol Life Sci. 2021 May;78(10):4521-4544. doi: 10.1007/s00018-021-03798-7. Epub 2021 Mar 26.
4
Development and prevalence of castration-resistant prostate cancer subtypes.
Neoplasia. 2020 Nov;22(11):566-575. doi: 10.1016/j.neo.2020.09.002. Epub 2020 Sep 25.
6
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.
Medicines (Basel). 2019 Jul 30;6(3):82. doi: 10.3390/medicines6030082.
7
Emerging Roles of Fibroblast Growth Factor 10 in Cancer.
Front Genet. 2018 Oct 24;9:499. doi: 10.3389/fgene.2018.00499. eCollection 2018.
10
Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first).
J Biol Chem. 2018 Mar 2;293(9):3410-3420. doi: 10.1074/jbc.RA117.000529. Epub 2018 Jan 10.

本文引用的文献

1
Identification of a cell of origin for human prostate cancer.
Science. 2010 Jul 30;329(5991):568-71. doi: 10.1126/science.1189992.
2
Influence of sex hormones on cancer progression.
J Clin Oncol. 2010 Sep 10;28(26):4038-44. doi: 10.1200/JCO.2009.27.4290. Epub 2010 Jul 19.
3
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
4
Hormone prevention strategies for breast, endometrial and ovarian cancers.
Gynecol Oncol. 2010 Aug 1;118(2):202-7. doi: 10.1016/j.ygyno.2010.03.014. Epub 2010 May 15.
5
E17K substitution in AKT1 in prostate cancer.
Br J Cancer. 2010 May 11;102(10):1491-4. doi: 10.1038/sj.bjc.6605673. Epub 2010 Apr 20.
6
Effect of dutasteride on the risk of prostate cancer.
N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.
7
The PKB/AKT pathway in cancer.
Curr Pharm Des. 2010 Jan;16(1):34-44. doi: 10.2174/138161210789941865.
8
Physiological regulation of Akt activity and stability.
Am J Transl Res. 2010 Jan 1;2(1):19-42.
9
Basal epithelial stem cells are efficient targets for prostate cancer initiation.
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5. doi: 10.1073/pnas.0913873107. Epub 2010 Jan 25.
10
New developments in the medical management of prostate cancer.
Mayo Clin Proc. 2010 Jan;85(1):77-86. doi: 10.4065/mcp.2009.0442.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验